Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999

Objective: Congestive heart failure and other cardiac complications are the most important causes of death in patients with beta Thalassemia major. Iron overloads and chronic anemia are the major causes of cardiac involvement. The purpose of this study was to evaluate the ability of echocardiographi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A Ghaemian, M Kosarian, A Adhami
Formato: article
Lenguaje:EN
FA
Publicado: Babol University of Medical Sciences 2001
Materias:
R
Acceso en línea:https://doaj.org/article/b339b3cd412848b48cd0212fd448d979
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b339b3cd412848b48cd0212fd448d979
record_format dspace
spelling oai:doaj.org-article:b339b3cd412848b48cd0212fd448d9792021-11-10T09:21:06ZEvaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 19991561-41072251-7170https://doaj.org/article/b339b3cd412848b48cd0212fd448d9792001-07-01T00:00:00Zhttp://jbums.org/article-1-2864-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170Objective: Congestive heart failure and other cardiac complications are the most important causes of death in patients with beta Thalassemia major. Iron overloads and chronic anemia are the major causes of cardiac involvement. The purpose of this study was to evaluate the ability of echocardiographic systolic function for diagnosis of cardiac involvement in patients with Thalassemia major. Methods: This descriptive study was done on patients with Thalassemia major (Over 12 years old) who referred to Booali Sina hospital in Sari. They were evaluated according to their ages, sex, age at beginning of transfusion of deferoxamine, the amount of deferoxamine, serum ferritin level, clinical manifestations, electrocardiogram, chest radiography and echocardiographic systolic function. Data was statistically analyzed by T-test. Findings: 55% of patients were male and the average age was 18±6 years. 22% of patients had systolic dysfunction. The difference of ejection fraction and fractional shortening between patients with and without cardiac involvement was significant (p<0.000). The age at beginning of deferoxamine and ferritin level in patients with cardiac complication was greater. The evaluation of cardiac function for determining cardiac involvement in patients with Thalassemia major with respect to clinical manifestations had a specificity of 76%, sensitivity of 41% and efficacy of 68%. Conclusion: When the patient is clinically symptomatic, systolic function will be impaired. Evaluation of echocardiographic systolic function is not enough for determining cardiac involvement in asymptomatic patients.A GhaemianM KosarianA AdhamiBabol University of Medical Sciencesarticlethalassemia majorechocardiographysystolic functionMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 3, Iss 3, Pp 43-46 (2001)
institution DOAJ
collection DOAJ
language EN
FA
topic thalassemia major
echocardiography
systolic function
Medicine
R
Medicine (General)
R5-920
spellingShingle thalassemia major
echocardiography
systolic function
Medicine
R
Medicine (General)
R5-920
A Ghaemian
M Kosarian
A Adhami
Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
description Objective: Congestive heart failure and other cardiac complications are the most important causes of death in patients with beta Thalassemia major. Iron overloads and chronic anemia are the major causes of cardiac involvement. The purpose of this study was to evaluate the ability of echocardiographic systolic function for diagnosis of cardiac involvement in patients with Thalassemia major. Methods: This descriptive study was done on patients with Thalassemia major (Over 12 years old) who referred to Booali Sina hospital in Sari. They were evaluated according to their ages, sex, age at beginning of transfusion of deferoxamine, the amount of deferoxamine, serum ferritin level, clinical manifestations, electrocardiogram, chest radiography and echocardiographic systolic function. Data was statistically analyzed by T-test. Findings: 55% of patients were male and the average age was 18±6 years. 22% of patients had systolic dysfunction. The difference of ejection fraction and fractional shortening between patients with and without cardiac involvement was significant (p<0.000). The age at beginning of deferoxamine and ferritin level in patients with cardiac complication was greater. The evaluation of cardiac function for determining cardiac involvement in patients with Thalassemia major with respect to clinical manifestations had a specificity of 76%, sensitivity of 41% and efficacy of 68%. Conclusion: When the patient is clinically symptomatic, systolic function will be impaired. Evaluation of echocardiographic systolic function is not enough for determining cardiac involvement in asymptomatic patients.
format article
author A Ghaemian
M Kosarian
A Adhami
author_facet A Ghaemian
M Kosarian
A Adhami
author_sort A Ghaemian
title Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
title_short Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
title_full Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
title_fullStr Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
title_full_unstemmed Evaluation of systolic function in patients with beta Thalassemia major in Booali Sina Hospital, Sari, 1999
title_sort evaluation of systolic function in patients with beta thalassemia major in booali sina hospital, sari, 1999
publisher Babol University of Medical Sciences
publishDate 2001
url https://doaj.org/article/b339b3cd412848b48cd0212fd448d979
work_keys_str_mv AT aghaemian evaluationofsystolicfunctioninpatientswithbetathalassemiamajorinbooalisinahospitalsari1999
AT mkosarian evaluationofsystolicfunctioninpatientswithbetathalassemiamajorinbooalisinahospitalsari1999
AT aadhami evaluationofsystolicfunctioninpatientswithbetathalassemiamajorinbooalisinahospitalsari1999
_version_ 1718440128526942208